Skip to main content
. 2021 Jan 27;10(1):e21256. doi: 10.2196/21256

Table 2.

Overview of collected variables.

Collection period Category Variable Unit(s) or categories
Collected before visit of late-effects clinic Childhood cancer type and treatment Primary childhood cancer diagnosis ICCC-3a classification
Treatment protocol Name and arm
Chemotherapy, per regimen TCDb
Radiotherapy field
  Cranial/craniospinal TCD, fractions (if applicable)
  Total body TCD, fractions (if applicable)
  Abdominal TCD, fractions (if applicable)
  Pancreas involvement TCD, fractions (if applicable)
Surgery procedure
  Autologous stem cell transplantation Yes / No, conditioning regimen
  Allogeneic stem cell transplantation Yes / No, conditioning regimen
Relapse Yes / No
Patient characteristics Sex Male / Female
Date of birth Date
Date of childhood cancer diagnosis Date
Date of study measurements (follow-up date) Date
Medical history Height at cancer diagnosis Centimeter
Weight at cancer diagnosis Kilogram
Growth hormone deficiency Yes / No
Growth hormone replacement Yes / No
Hypothyroidism Yes / No
Hypogonadism Yes / No
Hypocortisolism with steroid replacement Yes / No
Collected at visit of late-effects clinic Physical examination Height Centimeter
Weight Kilogram
Waist circumference Centimeter
Hip circumference Centimeter
Blood pressure mmHg
General health questionnaire Does the survivor have or has the survivor experienced
  High cholesterol Yes / No, age at diagnosis
  Hypertension Yes / No, age at diagnosis
  Diabetes mellitus Yes / No, age at diagnosis
  Myocardial infarction Yes / No, age at diagnosis
  Stroke Yes / No, age at diagnosis
Medication use Type, dose, age at start
Smoking status Yes / Former / No
Cardiovascular disease in family Relative, type of disease, age at diagnosis
Questionnaire to Assess Health enhancing physical activity N/Ac N/A
Dual-energy x-ray absorptiometry scan Total body fat Percentage
Z-score total body fat Z-score
Lean body mass Kilogram per m2
Appendicular lean body mass Kilogram per m2
6-minute walking test N/A Meter
Data determined from stored samples Serum biomarkers
  High-density lipoprotein mmol/L
  Low-density lipoprotein mmol/L
  Total cholesterol mmol/L
  Apolipoprotein-B g/L
  Glucose mmol/L
  Insulin pmol/L
  Adiponectin ug/mL
  Leptin ng/mL
  Uric acid mmol/L
  High sensitivity C-reactive protein mg/L
  IL-6d pg/mL
  hsTNFae pg/mL
  IL-1f pg/mL
  IGF-1g ug/L
  Creatinine mg/mmol
  Urea mmol/L
  LHh U/L
  FSHi U/L
  AMHj ug/L
  Estradiol pmol/L
  Testosterone nmol/L
DNA from blood/saliva N/A

aICCC-3: International Classification of Childhood Cancer, edition 3.

bTCD: total cumulative dose.

cN/A: not applicable.

dIL-6: interleukin-6.

ehsTNF: high-sensitivity tumor necrosis factor alpha.

fIL-1: interleukin-1.

gIGF-1: insulin-like growth factor 1.

hLH: luteinizing hormone.

iFSH: follicle stimulating hormone.

jAMH: anti-Müllerian hormone.